The epidermal growth factor receptor in healthy pregnancy and preeclampsia
Journal of Molecular Endocrinology · 01.01.2023 · 70 (1)
DOI: 10.1530/jme-22-0105 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Endocrinology, erschienen am 01.01.2023. Verfasst von Luca Clemente und 1 weiteren Autor:innen. Beteiligte Einrichtung: Perinatal Research Laboratories, Department of Obstetrics and Gynecology, University of Wisconsin, School of Medicine and Public Health, Madison, Wis…. Hauptthemen laut MEDLINE: Endothelial Cells, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
The epidermal growth factor receptor (EGFR) is expressed robustly in the placenta, and critical processes of pregnancy such as placental growth and trophoblast fusion are dependent on EGFR function. However, the role that aberrant EGFR signaling might play in the etiology and/or maintenance of preeclampsia (PE) remains largely unexplored. Recently, we have shown that overexpression of EGFR in cultured uterine artery endothelial cells (UAEC), which express little endogenous EGFR, remaps responsiveness away from vascular endothelial growth factor receptor (VEGFR) signaling and toward EGFR, suggesting that endothelial EGFR expression may be kept low to preserve VEGFR control of angiogenesis. Here we will consider the evidence for the possibility that the endothelial dysfunction observed in PE might in some cases result from elevation of endothelial EGFR. During pregnancy, trophoblasts are known to synthesize large amounts of EGFR protein, and the placenta regularly releases syncytiotrophoblast-derived exosomes and microparticles into the maternal circulation. Although there are no reports of elevated EGFR gene expression in preeclamptic endothelial cells, the ongoing shedding of placental vesicles into the vascular system raises the possibility that EGFR-rich vesicles might fuse with endothelium, thereby contributing to the symptoms of PE by interrupting angiogenesis and blocking pregnancy-adapted vasodilatory function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Perinatal Research Laboratories, Department of Obstetrics and Gynecology, University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Pediatrics, University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin, USA.
ORCID-Profile: Luca Clemente
Förderung
- NIGMS NIH HHS
- NICHD NIH HHS
Zitieren
APA
Clemente, L., & Bird, I. M. (2023). The epidermal growth factor receptor in healthy pregnancy and preeclampsia. Journal of Molecular Endocrinology, 70(1). https://doi.org/10.1530/jme-22-0105
Vancouver
Clemente L, Bird IM. The epidermal growth factor receptor in healthy pregnancy and preeclampsia. Journal of Molecular Endocrinology. 2023;70(1). doi:10.1530/jme-22-0105
BibTeX
@article{Clemente2023,
author = {Clemente, Luca and Bird, Ian M},
title = {The epidermal growth factor receptor in healthy pregnancy and preeclampsia},
journal = {Journal of Molecular Endocrinology},
year = {2023},
volume = {70},
number = {1},
doi = {10.1530/jme-22-0105}
}
EUVIMED